Purpose: Irritable Bowel Syndrome is one of the most prevalent functional GI disorders worldwide, making it a high-volume, high-engagement segment within gastroenterology. Although non-life-threatening, IBS significantly impacts quality of life and drives long-term healthcare utilization.
Upload here: https://gastroenterology-hepatology.utilitarianevents.com/upload-presentation/
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com
Keynote Points:
Very large and growing global patient population
Chronic symptom management requiring long-term solutions
Strong demand for OTC medications, probiotics, and dietary products
Expansion of low-FODMAP, personalized nutrition, and medical foods
Rising adoption of digital IBS management and telehealth platforms
High consumer engagement and self-care spending
Cross-selling opportunities across pharma, wellness, and lifestyle brands
Benefits:
Massive addressable market with recurring consumer demand
Multiple revenue channels: prescription, OTC, nutrition, and digital health
High brand loyalty driven by symptom relief and patient trust
Attractive ROI due to scalable, non-invasive treatment models
Ideal segment for subscription-based and direct-to-consumer strategies
Alignment with preventive, holistic, and patient-centric GI care trends